Cytosorbents Corp (CTSO)

Is Cytosorbents Corp (CTSO) A Buy Now?

According to our latest analysis, CTSO could be considered a Potential Buy, with 17 technical analysis indicators signaling 7 Buy signals, 4 signaling Sell signals and 6 Neutral signals. This might be a good time to open fresh positions on CTSO, as trading bullish markets is always a lot easier

1. RSI (Relative Strength Index): The RSI(14) value of 54.88 indicates that CTSO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
2. STOCH (Stochastic Oscillator): The STOCH value of 64.87 indicates that CTSO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.81 indicates that CTSO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
4. ADX (Average Directional Index): The ADX value of 20.31 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
5. CCI (Commodity Channel Index): A CCI(14) value of 86.85 indicates that CTSO is still overbought but not to an extreme extent.

Long-term CTSO price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Cytosorbents Corp financial reports and earnings history, Cytosorbents Corp (CTSO) stock could reach $34.24 by 2030, $193.43 by 2040 and $495.49 by 2050. See the projected annual prices until 2050 of the Cytosorbents Corp stock below:

• Cytosorbents Corp (CTSO) is expected to reach an average price of $82.23 in 2035, with a high prediction of $119.60 and a low estimate of $78.97. This indicates an +1,440% change from the last recorded price of $5.34.
• Cytosorbents Corp (CTSO) stock is projected to chart a bullish course in 2040, with an average price target of $175.43, representing an +3,185% change from its current level. The forecast ranges from a conservative $169.43 to a sky-high $193.43.
• Our analysts predict Cytosorbents Corp (CTSO) to change +4,868% by 2045, soaring from $250.24 to an average price of $265.29, potentially reaching $353.35. While $250.24 is the low estimate, the potential upside is significant.
• Cytosorbents Corp (CTSO) stock is expected to climb by 2050, reaching an average of $384.97, a +7,109% change from its current level. However, a wide range of estimates exists, with high and low targets of $495.49 and $400.97, respectively, highlighting the market's uncertainty.

Cytosorbents Corp Stock (CTSO) Year by Year Forecast